Skip to main content

Table 3 miRNAs and expression of their predicted targets as assessed by immunohistochemistry (IPX) for the initial cohort of 35 BRCA1 and 52 sporadic basal cancers

From: Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers

miRNA

miRNA expression up or down in BRCA1 vs. sporadic cancers

Fold change miRNA

adjusted p value (BRCA1 vs. sporadic)

Predicted target gene

IPX expression up or down in BRCA1 vs. sporadic cancers

Positive IPX in BRCA1, n (%)

Positive IPX in sporadic, n (%)

p value (chi square) positive or negative on IPX

p value (Mann–Whitney) on IPX score out of 7

hsa-miR-509-5p

Up

2.53

0.004

FOXP1

Down

6 (30 %)

37 (76 %)

<0.001

<0.001

hsa-miR-1285

Up

2.68

0.042

hsa-miR-1826

Up

3.02

<0.001

hsa-miR-220b

Up

3.76

<0.001

hsa-miR-1826

Up

3.02

<0.001

Cyclin D1

Down

8 (36 %)

30 (65 %)

0.025

0.004

hsa-miR-576-3p

Up

3.26

0.001

hsa-miR-638

Up

3.04

0.036

hsa-miR-30c-1*

Up

4.51

<0.001

NRP1

Down

2 (10 %)

23 (50 %)

0.002

0.003

hsa-miR-1285

Up

2.69

0.043

hsa-miR-129-3p

Up

6.03

<0.001

hsa-miR-29a*

Down

3.12

<0.001

CD99

Up

17 (85 %)

7 (37 %)

0.002

0.005

hsa-miR-130b*

Down

2.95

<0.006

hsa-miR-132*

Down

2.48

0.024

hsa-miR-340*

Down

3.09

0.028